CRVO Stock Analysis: Buy, Sell, or Hold?
CRVO - CervoMed Inc. Common Stock
$5.15
-0.02 (-0.39%)
▼
5d:
-17.99%
30d:
-35.46%
90d:
-25.15%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Get Alerted When CRVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CRVO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CRVO is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CRVO is down 18.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRVO is currently trading at $5.15, which is considered oversold relative to its 30-day fair value range of $6.14 to $8.04.
Technical Outlook: Technically, CRVO is in a downtrend. Immediate support is located at $4.90, while resistance sits at $7.41.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.43 (+335.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRVO is in a downtrend. Immediate support is located at $4.90, while resistance sits at $7.41.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.43 (+335.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.14 -
$8.04
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 335.5% below Wall St target ($22.43)
- WARNING: Recommendation downgraded due to -18.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$6.14 -
$8.04
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$4.90
Resistance Level
$7.41
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.56
Wall Street Target
$22.43
(+335.5%)
Revenue Growth (YoY)
-83.4%
Last updated: February 01, 2026 9:41 PM ET
Data refreshes hourly during market hours. Next update: 10:41 PM
Data refreshes hourly during market hours. Next update: 10:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRVO showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
